Black Rock Inc. Cassava Sciences Inc Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Black Rock Inc. holds 3,219,649 shares of SAVA stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,219,649

Previous 3,045,464 5.72%

Holding current value

$10.6 Million

Previous $61.8 Million 35.65%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.35 - $26.11 $2.15 Million - $4.55 Million	174,185 Added 5.72%	3,219,649 $39.8 Million
Q1 2024 May 10, 2024	BUY	$18.44 - $26.41 $148,423 - $212,574	8,049 Added 0.26%	3,045,464 $61.8 Million
Q4 2023 Feb 13, 2024	BUY	$12.64 - $30.11 $2.51 Million - $5.97 Million	198,431 Added 6.99%	3,037,415 $68.4 Million
Q3 2023 Nov 13, 2023	BUY	$16.64 - $25.32 $1.53 Million - $2.33 Million	92,076 Added 3.35%	2,838,984 $47.2 Million
Q2 2023 Aug 11, 2023	BUY	$21.59 - $27.88 $2.68 Million - $3.46 Million	124,231 Added 4.74%	2,746,908 $67.4 Million
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $1.36 Million - $2.12 Million	58,149 Added 2.27%	2,622,677 $63.3 Million
Q4 2022 Feb 13, 2023	BUY	$27.82 - $44.16 $2.19 Million - $3.48 Million	78,807 Added 3.17%	2,564,528 $75.8 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $2.87 Million - $8.99 Million	-175,999 Reduced 6.61%	2,485,721 $104 Million
Q2 2022 Aug 12, 2022	SELL	$17.22 - $38.47 $726,012 - $1.62 Million	-42,161 Reduced 1.56%	2,661,720 $74.8 Million
Q1 2022 May 12, 2022	SELL	$32.6 - $53.05 $1.86 Million - $3.03 Million	-57,097 Reduced 2.07%	2,703,881 $100 Million
Q4 2021 Feb 10, 2022	BUY	$36.77 - $90.91 $5.78 Million - $14.3 Million	157,100 Added 6.03%	2,760,978 $121 Million
Q3 2021 Nov 09, 2021	BUY	$41.79 - $135.3 $6.35 Million - $20.6 Million	151,999 Added 6.2%	2,603,878 $162 Million
Q2 2021 Aug 11, 2021	BUY	$32.15 - $89.72 $78.8 Million - $220 Million	2,451,879 New	2,451,879 $209 Million

Others Institutions Holding SAVA

# of Institutions

133

Shares Held

14.2M

Call Options Held

962K

Put Options Held

864K

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $132M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account